The metabolic fate of doubly labelled lactose-[13C,15N]ureide after pre-dosing with different ureides - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue European Journal of Clinical Nutrition Année : 2010

The metabolic fate of doubly labelled lactose-[13C,15N]ureide after pre-dosing with different ureides

Klaus D. Wutzke
  • Fonction : Auteur correspondant
  • PersonId : 882908

Connectez-vous pour contacter l'auteur
Johanna Mix
  • Fonction : Auteur

Résumé

Background: To date, the measurement of the orocaecal transit time (OCTT) with lactose-[13C]ureide usually requires a pre-dosing with the analogous substrate in its unlabelled form. Objective: In the present study, the enzyme induction provoked by different unlabelled sugar ureides in OCTT measurements when using doubly labelled lactose-[13C,15N]ureide (DLLU) was evaluated. Methods: Thirteen healthy adults (age: 22-58 years) received 500 mg DLLU together with a standardised breakfast. Expired air, urine, and faeces were collected over a period of 14, 48, and 72 h, respectively. After 1 and 2 weeks, the test was repeated after pre-dosing of 3x120 mg glucose ureide (GU) and 3x200 mg cellobiose ureide (CU), respectively, on the day prior to study begin. The 13C- and 15N-enrichments were measured by isotope ratio mass spectrometry. The OCTT was calculated by the detection of a significant 13CO2-rise. Results: In comparison to the period without pre-dosing (7.8±2.2 hours) the measured OCTT was significantly lowered either after GU pre-dosing (5.8±1.9 hours, P= 0.033) or CU pre-dosing (6.0±2.2 hours, P= 0.039). The respective renal 13C- and 15N-excretions amounted to 24.5 and 45.6, 24.7 and 54.0, and 22.5 and 50.1 %, respectively, whereas the faecal 13C- and 15N-excretions amounted to 12.1 and 45.8, 4.8 and 21.5, and 9.6 and 39.8 %, respectively. Conclusions: Pre-dosing with unlabelled GU and CU prior to the administration of DLLU led to an unequivocal induction of the enzyme activity and resulted in a definitive estimation of the OCTT, clearly demonstrating that glucose-[13C]ureide is the matrix of the bacterial degradation in the caecum.
Fichier principal
Vignette du fichier
PEER_stage2_10.1038%2Fejcn.2010.84.pdf (126.9 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)
Loading...

Dates et versions

hal-00537679 , version 1 (19-11-2010)

Identifiants

Citer

Klaus D. Wutzke, Johanna Mix. The metabolic fate of doubly labelled lactose-[13C,15N]ureide after pre-dosing with different ureides. European Journal of Clinical Nutrition, 2010, ⟨10.1038/ejcn.2010.84⟩. ⟨hal-00537679⟩

Collections

PEER
20 Consultations
93 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More